PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-10-13

Date Title Company
13-Oct-2020 Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020 Verona Pharma
13-Oct-2020 F4 Pharma Announces Formation of Scientific Advisory Board F4 Pharma
13-Oct-2020 Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation for PBP1510 for Treatment of Pancreatic Cancer Prestige Biopharma
13-Oct-2020 Hofseth BioCare ASA: PROGO®’s BIOACTIVE PEPTIDES™ TO SUPPORT HEALTHY IRON LEVELS TO BE LAUNCHED IN THE U.S. Hofseth BioCare
13-Oct-2020 SHIONOGI ANNOUNCES PUBLICATION OF TWO STUDIES IN THE LANCET INFECTIOUS DISEASES HIGHLIGHTING THE EFFICACY AND SAFETY OF CEFIDEROCOL FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS Shionogi
13-Oct-2020 New Device for Detecting Traumatic Brain Injury ‘On the Spot’ University of Birmingham
13-Oct-2020 PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE Ketchum
13-Oct-2020 PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS Ketchum
13-Oct-2020 Medical Nitroglycerin Sprays Market Report Explored in Latest Research 2020-2030 MARKITWIRED
13-Oct-2020 Scottish Medicines Consortium Accepts DARZALEX®▼ (daratumumab) Subcutaneous Injection and IMBRUVICA® (ibrutinib) Combination Therapy for Treatment of Blood Cancers in Scotland Scottish Medicines Consortium
13-Oct-2020 Lung Cancer Surgery Market to Reflect Impressive Growth Rate During 2019-2029 MARKITWIRED
13-Oct-2020 Amino Acid Disorder Treatment Market to Witness an Outstanding Growth During 2017 – 2026 MARKITWIRED
13-Oct-2020 Call for more BAME representation in COVID-19 trials will fail if long-held diversity challenges are not addressed Innovative Trials
13-Oct-2020 Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis Evelo Biosciences
13-Oct-2020 Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases Secarna Pharmaceuticals GmbH & Co. KG
13-Oct-2020 Cerebrospinal Fluid (CSF) Management Market Size, Industry  Share, Growth, Trends, Segments, Demand, Revenue and Forecast Research to 2027 CDN Newswire
13-Oct-2020 MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds MorphoSys AG
13-Oct-2020 BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 BioGX
13-Oct-2020 Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis Evelo Biosciences
13-Oct-2020 Cambridge Research & Development Offers New Sanitizing Technology for Licensing - 'Self-Sanitizing Door Control System' to Combat Pathogenic Community Spread Cambridge Research & Development